211 related articles for article (PubMed ID: 23193190)
21. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.
Fiorillo E; Orrú V; Stanford SM; Liu Y; Salek M; Rapini N; Schenone AD; Saccucci P; Delogu LG; Angelini F; Manca Bitti ML; Schmedt C; Chan AC; Acuto O; Bottini N
J Biol Chem; 2010 Aug; 285(34):26506-18. PubMed ID: 20538612
[TBL] [Abstract][Full Text] [Related]
22. The potential of PTPN22 as a therapeutic target for rheumatoid arthritis.
Carmona FD; Martín J
Expert Opin Ther Targets; 2018 Oct; 22(10):879-891. PubMed ID: 30251905
[TBL] [Abstract][Full Text] [Related]
23. Protein tyrosine phosphatase PTPN22 regulates IL-1β dependent Th17 responses by modulating dectin-1 signaling in mice.
Purvis HA; Clarke F; Jordan CK; Blanco CS; Cornish GH; Dai X; Rawlings DJ; Zamoyska R; Cope AP
Eur J Immunol; 2018 Feb; 48(2):306-315. PubMed ID: 28948613
[TBL] [Abstract][Full Text] [Related]
24. Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity.
Fousteri G; Liossis SN; Battaglia M
Clin Immunol; 2013 Dec; 149(3):556-65. PubMed ID: 24269925
[TBL] [Abstract][Full Text] [Related]
25. [Research progress of several protein tyrosine phosphatases in diabetes].
Chen M; Sun JP; Liu J; Yu X
Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
[TBL] [Abstract][Full Text] [Related]
26. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background.
Zikherman J; Hermiston M; Steiner D; Hasegawa K; Chan A; Weiss A
J Immunol; 2009 Apr; 182(7):4093-106. PubMed ID: 19299707
[TBL] [Abstract][Full Text] [Related]
27. Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?
Burn GL; Svensson L; Sanchez-Blanco C; Saini M; Cope AP
FEBS Lett; 2011 Dec; 585(23):3689-98. PubMed ID: 21515266
[TBL] [Abstract][Full Text] [Related]
28. The common, autoimmunity-predisposing 620Arg > Trp variant of PTPN22 modulates macrophage function and morphology.
Li M; Beauchemin H; Popovic N; Peterson A; d'Hennezel E; Piccirillo CA; Sun C; Polychronakos C
J Autoimmun; 2017 May; 79():74-83. PubMed ID: 28237724
[TBL] [Abstract][Full Text] [Related]
29. Exploiting novel tailored immunotherapies of type 1 diabetes: Short interfering RNA delivered by cationic liposomes enables efficient down-regulation of variant PTPN22 gene in T lymphocytes.
Pellegrino M; Ceccacci F; Petrini S; Scipioni A; De Santis S; Cappa M; Mancini G; Fierabracci A
Nanomedicine; 2019 Jun; 18():371-379. PubMed ID: 30439564
[TBL] [Abstract][Full Text] [Related]
30. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness.
Zhang J; Zahir N; Jiang Q; Miliotis H; Heyraud S; Meng X; Dong B; Xie G; Qiu F; Hao Z; McCulloch CA; Keystone EC; Peterson AC; Siminovitch KA
Nat Genet; 2011 Aug; 43(9):902-7. PubMed ID: 21841778
[TBL] [Abstract][Full Text] [Related]
31. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.
Li K; Hou X; Li R; Bi W; Yang F; Chen X; Xiao P; Liu T; Lu T; Zhou Y; Tian Z; Shen Y; Zhang Y; Wang J; Fang H; Sun J; Yu X
J Biol Chem; 2019 May; 294(21):8653-8663. PubMed ID: 30979725
[TBL] [Abstract][Full Text] [Related]
32. A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus.
Orrú V; Tsai SJ; Rueda B; Fiorillo E; Stanford SM; Dasgupta J; Hartiala J; Zhao L; Ortego-Centeno N; D'Alfonso S; ; Arnett FC; Wu H; Gonzalez-Gay MA; Tsao BP; Pons-Estel B; Alarcon-Riquelme ME; He Y; Zhang ZY; Allayee H; Chen XS; Martin J; Bottini N
Hum Mol Genet; 2009 Feb; 18(3):569-79. PubMed ID: 18981062
[TBL] [Abstract][Full Text] [Related]
33. Analysis of PTPN22 C1858T gene polymorphism in cases with type 1 diabetes of Azerbaijan, Northwest Iran.
Almasi S; Aliparasti MR; Yazdchi-Marandi L; Aliasgarzadeh A; Sioofy-Khojine A; Mesri A; Zamani F
Cell Immunol; 2014; 292(1-2):14-8. PubMed ID: 25243643
[TBL] [Abstract][Full Text] [Related]
34. PTPN22 interacts with EB1 to regulate T-cell receptor signaling.
Zhang X; Yu Y; Bai B; Wang T; Zhao J; Zhang N; Zhao Y; Wang X; Wang B
FASEB J; 2020 Jul; 34(7):8959-8974. PubMed ID: 32469452
[TBL] [Abstract][Full Text] [Related]
35. rs2476601 T allele (R620W) defines high-risk PTPN22 type I diabetes-associated haplotypes with preliminary evidence for an additional protective haplotype.
Steck AK; Baschal EE; Jasinski JM; Boehm BO; Bottini N; Concannon P; Julier C; Morahan G; Noble JA; Polychronakos C; She JX; Eisenbarth GS;
Genes Immun; 2009 Dec; 10 Suppl 1(Suppl 1):S21-6. PubMed ID: 19956096
[TBL] [Abstract][Full Text] [Related]
36. Preparation and In Vitro Evaluation of RITUXfab-Decorated Lipoplexes to Improve Delivery of siRNA Targeting C1858T PTPN22 Variant in B Lymphocytes.
Arena A; Belcastro E; Accardo A; Sandomenico A; Pagliarosi O; Rosa E; Petrini S; Conti LA; Giorda E; Corsetti T; Schiaffini R; Morelli G; Fierabracci A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008834
[TBL] [Abstract][Full Text] [Related]
37. Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function.
Brownlie RJ; Miosge LA; Vassilakos D; Svensson LM; Cope A; Zamoyska R
Sci Signal; 2012 Nov; 5(252):ra87. PubMed ID: 23193160
[TBL] [Abstract][Full Text] [Related]
38. C1858T Polymorphism of Protein Tyrosine Phosphatase Non-receptor Type 22 (PTPN22): an eligible target for prevention of type 1 diabetes?
Prezioso G; Comegna L; Di Giulio C; Franchini S; Chiarelli F; Blasetti A
Expert Rev Clin Immunol; 2017 Mar; 13(3):189-196. PubMed ID: 27892782
[TBL] [Abstract][Full Text] [Related]
39. The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population.
Laberge GS; Birlea SA; Fain PR; Spritz RA
Pigment Cell Melanoma Res; 2008 Apr; 21(2):206-8. PubMed ID: 18426414
[TBL] [Abstract][Full Text] [Related]
40. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
van Oene M; Wintle RF; Liu X; Yazdanpanah M; Gu X; Newman B; Kwan A; Johnson B; Owen J; Greer W; Mosher D; Maksymowych W; Keystone E; Rubin LA; Amos CI; Siminovitch KA
Arthritis Rheum; 2005 Jul; 52(7):1993-8. PubMed ID: 15986374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
